Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma Feb 19, 2020 7:00am EST
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors Dec 19, 2019 7:00am EST
Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting Dec 09, 2019 10:00am EST
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering Nov 21, 2019 7:00am EST
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants Nov 18, 2019 7:00am EST
